Acadian Asset Management »

Stoke Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $447k 14k 31.63
2024-09-30 $22k 1.8k 11.92
2022-12-31 $711k 77k 9.21